Date published: 2026-4-1

1-800-457-3801

SCBT Portrait Logo
Seach Input

Slc6a16 Inhibitors

Slc6a16 inhibitors are a class of chemical compounds specifically designed to target and block the activity of the **Slc6a16** protein, a member of the solute carrier family 6 (SLC6) of transporters. The SLC6 family is primarily known for its role in the sodium- and chloride-dependent transport of neurotransmitters and amino acids across cellular membranes. Slc6a16 is thought to be involved in the transport of specific amino acids or neurotransmitters, contributing to processes related to nutrient uptake and signaling. By inhibiting Slc6a16, these compounds disrupt the normal transport function of this protein, which in turn affects the balance and distribution of the substrates it is responsible for moving across the cell membrane.

Studying Slc6a16 inhibitors allows researchers to explore the transporter's role in regulating intracellular and extracellular concentrations of amino acids or neurotransmitters, offering insights into its broader impact on cellular metabolism and signaling pathways. When Slc6a16 is inhibited, researchers can observe the downstream effects on cellular processes such as protein synthesis, neurotransmission, or energy production, depending on the specific substrate transported by this protein. Inhibition of Slc6a16 also provides a tool for investigating how this transporter interacts with other members of the SLC family and how it integrates into larger networks of nutrient and neurotransmitter transport. Through the use of Slc6a16 inhibitors, scientists gain a deeper understanding of the importance of amino acid and neurotransmitter balance in maintaining cellular function and how the disruption of specific transport systems can lead to alterations in cellular homeostasis and metabolism.

SEE ALSO...

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Fluoxetine

54910-89-3sc-279166
500 mg
$318.00
9
(1)

A selective serotonin reuptake inhibitor (SSRI) that may indirectly affect SLC6A16 by altering neurotransmitter availability.

(±)-Baclofen

1134-47-0sc-200464
sc-200464A
1 g
5 g
$56.00
$258.00
(1)

A GABA_B receptor agonist that may indirectly affect SLC6A16 through modulating neurotransmitter levels.

1-Adamantylamine

768-94-5sc-251475
sc-251475A
1 g
25 g
$39.00
$147.00
(0)

Known to increase dopamine release, potentially altering the activity of dopamine-related SLC6 family members.

Tianeptine

66981-73-5sc-213044
sc-213044A
10 mg
50 mg
$250.00
$422.00
(0)

An atypical antidepressant that enhances serotonin uptake in some brain regions, possibly affecting SLC6A16 indirectly.

Guanfacine

29110-47-2sc-353618
200 mg
$1900.00
(0)

An α2A-adrenergic receptor agonist that might influence neurotransmitter transporters indirectly, including SLC6A16.

Escitalopram

128196-01-0sc-357349
sc-357349A
10 mg
50 mg
$131.00
$416.00
2
(0)

A highly selective SSRI, potentially affecting SLC6A16 indirectly through serotonin system modulation.